Characteristic Median (inter-quartile range) or %
Date of HAART initiation February 1998 (March 1997, February 2000)
Cumulative NRTI use-years 3.3 (1.6, 5.1)
Cumulative zidovudine use-years 1.0 (0.5, 1.9)
Cumulative stavudine use-years 0.5 (0.0, 1.0)
Cumulative abacavir use-years 0.0 (0.0, 0.0)
Cumulative tenofovir use-years
  1. (0.0, 0.0)
Cumulative PI use-years 0.5 (0.2, 0.6)
Cumulative NNRTI use-years 0.0 (0.0, 0.4)
Enrollment Period 1994-1995 91%
Age, yearsa 38.7 (33.6, 44.1)
Race/Ethnicity
African-American
Hispanic
White
Other
 56%
25%
16%
2%
Alcohol Use>3 drinks/weeka 18%
Cigarette Smokinga
Current
Former
Never
 51%
22%
27%
Marijuana usesince last visit 18%
Injection drug, heroin, cocaine, or crack usesince last visit 13%
Quality of Lifea 65.5 (48.4, 79.5)
CESD> 16a 49%
Highest education level attained
Graduated college or higher
Some College
Completed High School
Did not complete high school
 8%
25%
31%
37%
Have AIDSa 40%
CD4 cell count, cells/mm3a
<100
100-<200
200-<500
≥ 500
 15%
18%
51%
15%
log10HIVRNA, copies/mla 4.2 (3.3, 4.8)
aascertained from visit immediately prior to initiating HAART
Table 1: Participant characteristics at initial HAART visit, N = 1177.
Goto home»